内在の電気活動が小細胞肺がんの進行を促す
Paola Peinado1, Marco Stazi1, Claudio Ballabio1
1Cancer Neuroscience Laboratory, Francis Crick Institute, London, UK.
Nature
|February 12, 2025
まとめ
小細胞肺がん (SCLC) の神経内分泌 (NE) 細胞は電気的に刺激され,腫瘍の悪性腫瘍と転移を誘発する. これらのNE細胞は,非NE細胞によってサポートされる酸化リン酸化に依存し,自己持続的な腫瘍サイクルを生み出します.
科学分野:
- 癌 生物学
- 神経科学
- 代謝の調節
背景:
- 神経受容体と神経内分泌 (NE) 変換は癌の進行と関連しています.
- ニューロンの重要な特徴である 電気的興奮性は がん細胞ではほとんど未知のものです
- 小細胞肺がん (SCLC) は,NEと非NE細胞のサブ集団を特徴とする攻撃的なNEがんである.
研究 の 目的:
- SCLCにおける電気刺激性の存在と役割を調査する.
- SCLCにおけるNE細胞と非NE細胞の代謝相互作用を理解する.
- SCLCの進行,内置,神経特性の関係を探求する.
主な方法:
- NE細胞の興奮性を評価するための電気生理学的記録
- エネルギー依存性を決定する代謝分析 (酸化性リン酸化対糖解).
- 進行中の腫瘍内置とSCLC細胞の神経マーカーの分析.
主要な成果:
- NE細胞は,非NE細胞ではなく,電気的興奮とアクションポテンシャル発火を示し,SCLCの悪性腫瘍を促進します.
- NE細胞は,典型的な癌細胞の甘分化とは対照的に,酸化性リン酸化への異常な依存を示している.
- 非NE細胞は,アストロサイトとニューロンの相互作用に似て,NE細胞に代謝のサポートを提供します.
- SCLCの進行には,神経内膜の変異,腫瘍内異質性の増加,および癌細胞の神経特性の強化が含まれます.
結論:
- 癌細胞の内在的な電気活動はSCLCの悪性発症と転移の可能性を誘発する.
- 電気的活動と代謝のサポートにより 腫瘍自体の悪循環が 長期的な腫瘍形成を促進します
- 電気的興奮性や代謝依存症をターゲットにすることで,SCLCの新たな治療戦略を提供することができる.
関連する概念動画
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
The Intrinsic Apoptotic Pathway
6.1K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.1K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K


